466 related articles for article (PubMed ID: 14654667)
1. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
2. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
3. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
Moats RA; Moseley KD; Koch R; Nelson M
Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
[TBL] [Abstract][Full Text] [Related]
4. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
[TBL] [Abstract][Full Text] [Related]
5. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
[TBL] [Abstract][Full Text] [Related]
7. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
[TBL] [Abstract][Full Text] [Related]
8. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
[TBL] [Abstract][Full Text] [Related]
9. Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.
Vogel KR; Arning E; Wasek BL; Bottiglieri T; Gibson KM
Mol Genet Metab; 2013; 110 Suppl(0):S71-8. PubMed ID: 23999161
[TBL] [Abstract][Full Text] [Related]
10. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
Yano S; Moseley K; Fu X; Azen C
PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
[TBL] [Abstract][Full Text] [Related]
12. Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc/LAT1 complex.
Møller LB; Paulsen M; Koch R; Moats R; Guldberg P; Güttler F
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S119-23. PubMed ID: 16176881
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
Martynyuk AE; Ucar DA; Yang DD; Norman WM; Carney PR; Dennis DM; Laipis PJ
Epilepsia; 2007 Jun; 48(6):1143-50. PubMed ID: 17484755
[TBL] [Abstract][Full Text] [Related]
14. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
Gropper SS; Yannicelli S; White BD; Medeiros DM
Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
[TBL] [Abstract][Full Text] [Related]
15. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
16. The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations.
van Vliet D; van der Goot E; van Ginkel WG; van Faassen HJR; de Blaauw P; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Mol Genet Metab; 2022 Jan; 135(1):27-34. PubMed ID: 34974973
[TBL] [Abstract][Full Text] [Related]
17. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
Matalon R; Michals-Matalon K; Bhatia G; Burlina AB; Burlina AP; Braga C; Fiori L; Giovannini M; Grechanina E; Novikov P; Grady J; Tyring SK; Guttler F
J Inherit Metab Dis; 2007 Apr; 30(2):153-8. PubMed ID: 17334706
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
Möller HE; Weglage J; Wiedermann D; Ullrich K
J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
[TBL] [Abstract][Full Text] [Related]
19. Large neutral amino acids in the treatment of phenylketonuria (PKU).
Matalon R; Michals-Matalon K; Bhatia G; Grechanina E; Novikov P; McDonald JD; Grady J; Tyring SK; Guttler F
J Inherit Metab Dis; 2006 Dec; 29(6):732-8. PubMed ID: 16988900
[TBL] [Abstract][Full Text] [Related]
20. Expression of calpastatin, minopontin, NIPSNAP1, rabaptin-5 and neuronatin in the phenylketonuria (PKU) mouse brain: possible role on cognitive defect seen in PKU.
Surendran S; Tyring SK; Matalon R
Neurochem Int; 2005 Jun; 46(8):595-9. PubMed ID: 15863237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
